ZAMBON, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 705
AS - Asia 322
EU - Europa 280
OC - Oceania 39
AF - Africa 24
SA - Sud America 23
Continente sconosciuto - Info sul continente non disponibili 2
Totale 1.395
Nazione #
US - Stati Uniti d'America 670
CN - Cina 84
IN - India 77
IT - Italia 70
GB - Regno Unito 57
FR - Francia 38
JP - Giappone 38
AU - Australia 37
CA - Canada 31
DE - Germania 30
TR - Turchia 27
NL - Olanda 25
TW - Taiwan 15
HK - Hong Kong 12
IR - Iran 10
EG - Egitto 9
MY - Malesia 9
SG - Singapore 9
BG - Bulgaria 7
ES - Italia 7
TH - Thailandia 7
VN - Vietnam 7
DZ - Algeria 6
AR - Argentina 5
BE - Belgio 5
BR - Brasile 5
FI - Finlandia 5
IE - Irlanda 5
LY - Libia 5
CL - Cile 4
CO - Colombia 4
DK - Danimarca 4
HU - Ungheria 4
ID - Indonesia 4
IL - Israele 4
IQ - Iraq 4
RU - Federazione Russa 4
ZA - Sudafrica 4
CH - Svizzera 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
MX - Messico 3
PK - Pakistan 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
EU - Europa 2
KW - Kuwait 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SE - Svezia 2
AT - Austria 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
MT - Malta 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
PS - Palestinian Territory 1
RS - Serbia 1
SA - Arabia Saudita 1
UA - Ucraina 1
Totale 1.395
Città #
Ashburn 186
Fairfield 50
Padova 30
Santa Cruz 26
Seattle 25
Bengaluru 22
Woodbridge 22
Houston 20
Cambridge 18
Redmond 17
Wilmington 16
Beijing 15
Ann Arbor 13
Taipei 13
Delhi 12
Guangzhou 12
Buffalo 11
Sydney 11
Brisbane 10
Des Moines 10
San Diego 10
Chicago 9
Frankfurt am Main 9
London 9
Rome 8
Shanghai 8
Toronto 7
Utrecht 7
Las Vegas 6
Liverpool 6
Los Angeles 6
Milan 6
Paris 6
Tokyo 6
Ankara 5
Cairo 5
Duncan 5
Durham 5
Helsinki 5
Istanbul 5
Lucknow 5
Melbourne 5
Shizuoka 5
Singapore 5
Skikda 5
Tripoli 5
Budapest 4
Dublin 4
Gurgaon 4
Kyoto 4
Madrid 4
Moscow 4
Nanjing 4
New York 4
Ottawa 4
San Francisco 4
Tianjin 4
Antalya 3
Boardman 3
Can Tho 3
Guwahati 3
Hong Kong 3
Ilford 3
Kuala Lumpur 3
Kurashiki 3
Lappersdorf 3
Makassar 3
Nanchang 3
Philadelphia 3
Rotterdam 3
Santiago 3
Wuhan 3
Zhengzhou 3
Adelaide 2
Al Hillah 2
Atlanta 2
Berlin 2
Bogotá 2
Boston 2
Brussels 2
Carbondale 2
Carmel 2
Central 2
Chennai 2
Clearwater 2
Coimbatore 2
Columbus 2
Cookstown 2
Dallas 2
Dieppe 2
Dikirnis 2
Edmonton 2
Ferentino 2
Fullerton 2
Grassobbio 2
Groningen 2
Harrison 2
Hawley 2
Hebei 2
Henderson 2
Totale 848
Nome #
SGLT2 Inhibitors and the Diabetic Kidney, file e14fb269-05b8-3de1-e053-1705fe0ac030 768
Lipid Profile and Vascular Remodelling in Young Dyslipidemic Subjects Treated with Nutraceuticals Derived from Red Yeast Rice, file e14fb26e-7b9f-3de1-e053-1705fe0ac030 130
The long-term safety and efficacy of fibrates in patients with hypertriglyceridemia: Real-life data from a lipid clinic cohort, file e14fb26d-07fb-3de1-e053-1705fe0ac030 118
The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: Conceptual framework and therapeutic potential, file e14fb26b-e240-3de1-e053-1705fe0ac030 109
Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia, file e14fb26d-4d48-3de1-e053-1705fe0ac030 79
Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity, file e14fb26c-9c94-3de1-e053-1705fe0ac030 78
Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients, file e14fb26d-ece6-3de1-e053-1705fe0ac030 37
Lomitapide does not alter PCSK9 and Lp(a) levels in homozygous familial hypercholesterolemia patients: analysis on cytokines and lipid profile, file e14fb26e-f23e-3de1-e053-1705fe0ac030 25
Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook, file 4a6488a9-a2ba-42e8-a6ad-4bf56ecb6b4b 16
Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies, file e14fb270-2dcb-3de1-e053-1705fe0ac030 15
Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar, file 6a47cefd-e824-4223-9035-8c05f2bd96e5 8
Reducing cholesterol levels to decrease cardiovascular events: The role of new proprotein convertase subtilisin/kexin type 9 inhibitors, file e14fb269-86c9-3de1-e053-1705fe0ac030 8
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN), file e14fb26e-8a72-3de1-e053-1705fe0ac030 8
Efficacy and safety of inclisiran a newly approved FDA drug: a systematic review and pooled analysis of available clinical studies, file e14fb270-3443-3de1-e053-1705fe0ac030 8
The new ACC/AHA guidelines on the treatment of dyslipidemia: cons., file e14fb267-b99d-3de1-e053-1705fe0ac030 7
HDL Cholesterol Efflux and Serum Cholesterol Loading Capacity Alterations Associate to Macrophage Cholesterol Accumulation in FH Patients with Achilles Tendon Xanthoma, file 844d9c52-d99e-4967-be4a-1f7b093ffcd8 4
A subgroup analysis of the ODYSSEY APPRISE study: safety and efficacy of alirocumab in the Italian cohort, file eba8f85a-8411-4c98-9ca5-fe00a1c39c18 4
Efficacy and safety of lomitapide in familial chylomicronaemia syndrome, file 04a462bf-a35f-4503-887a-ccd2bd9bc474 3
I farmaci che riducono la mortalità: gli ipolipemizzanti, file e14fb26b-56cc-3de1-e053-1705fe0ac030 3
The spoils of war and the long-term spoiling of health conditions of entire nations, file e14fb270-34b3-3de1-e053-1705fe0ac030 3
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy, file e14fb268-b3e3-3de1-e053-1705fe0ac030 2
Plasma phospholipid fatty acid composition, lipid oxidation and inflammatory parameters in a population of fishermen, file e14fb26b-311e-3de1-e053-1705fe0ac030 2
OMEGA-3 POLYUNSATURATED FATTY ACIDS SUPPLEMENTATION AND CARDIOVASCULAR OUTCOMES: DO FORMULATION, DOSAGE, AND BASELINE CARDIOVASCULAR RISK MATTER? AN UPDATED META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS, file e14fb26d-3691-3de1-e053-1705fe0ac030 2
New and Emerging Therapies for Dyslipidemia, file 31ee923f-88d0-4886-94d2-fd0b9811a4e2 1
Lipoprotein(a) and family history for cardiovascular disease in paediatric patients: A new frontier in cardiovascular risk stratification. Data from the LIPIGEN paediatric group, file 36b4f18e-76fe-4c51-9405-1182f4c0dc8e 1
Lipid-lowering in diabetes: An update, file c1d4495a-171f-49aa-b7f4-07e143eef4d9 1
Validity of the ATP III diagnostic criteria for the metabolic syndrome in an elderly Italian Caucasian population the Italian longitudinal study on aging, file e14fb267-784d-3de1-e053-1705fe0ac030 1
Residual vascular risk in diabetes - Will the SPPARM alpha concept hold the key?, file e14fb26b-c4d1-3de1-e053-1705fe0ac030 1
Omega n-3 Supplementation: Exploring the Cardiovascular Benefits Beyond Lipoprotein Reduction, file e14fb26d-9bb8-3de1-e053-1705fe0ac030 1
Totale 1.443
Categoria #
all - tutte 3.976
article - articoli 3.918
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201940 0 0 0 0 0 0 0 0 0 0 25 15
2019/202093 5 2 0 3 4 3 2 5 12 17 24 16
2020/2021188 10 14 8 14 6 5 8 21 32 38 19 13
2021/2022352 11 18 12 14 19 11 46 37 58 27 65 34
2022/2023404 26 47 53 41 27 32 47 33 29 38 28 3
2023/2024323 4 1 9 8 11 67 102 19 48 32 22 0
Totale 1.443